SAGE PRO

Home / Research / Equitas Small Finance Bank

SAGE PRO · ORIGINAL EQUITY RESEARCH

Equitas Small Finance Bank — Q2 FY27 Results Analysis

Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO succession is another execution hinge. Compare with Ujjivan and Jana on recurring credit cost and secured portfolio economics. The raised FY27 ROA ambition is a measurable delivery…

Published · Quarter Q2 FY27 · EQUITASBNK

StanceWATCH
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

PAT YoY

Prior year₹24 cr
Current₹218 cr

Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.

CHART 2

Growth

Advances30%
Deposits19%

Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.

CHART 3

FY27 ROA guidance

Previous1.2%
Revised1.35%

Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.

CHART 4

Quarterly net profit · Standalone

Sep 25₹24 cr
Dec 25₹90 cr
Mar 26₹213 cr
Jun 26₹184 cr
Sep 26₹218 cr

SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified):

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO…

Recovery is material; NIM fell QoQ.

Watch: ROA, adjusted credit cost, funding and successor approval.

RESEARCH INSIGHT

Funding trails credit.

Funding trails credit.

Watch: Review the dated investment thesis and monitoring tests in the full report.

RESEARCH INSIGHT

Guidance not actual; Q2 ROA 1.31%.

Guidance not actual; Q2 ROA 1.31%.

Watch: Review the dated investment thesis and monitoring tests in the full report.

RESEARCH INSIGHT

Standalone profit: ₹24.0 cr to ₹218.0 cr over five quarters

Five same-basis quarterly profit observations, Sep 2025–Sep 2026. This historical series may differ from bank-only figures in the decision summary; no mixing of reporting bases.

Watch: Separate recurring earnings from one-offs; check the original filings before valuation.

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

SAGE PRO | 16 November 2026 | Available-source research | WATCH / conditional research stance

Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO succession is another execution hinge. Compare with Ujjivan and Jana on recurring credit cost and secured portfolio economics. The raised FY27 ROA ambition is a measurable delivery test.

Operating performance and earnings quality

PAT ₹218 crore vs ₹24 crore YoY; advances +30%, deposits +19%; ROA 1.31%.

Key takeaways

  • Financial 24/30: earnings recovery and credit growth, but NIM fell QoQ.
  • Outlook 20/25: FY27 ROA guidance raised to 1.35% vs 1.2%.
  • Q&A 16/20: succession process, asset quality and vehicle seasonality explained.

Capital 11/15: CRAR 20.92%, CD ratio 90.53%, Tier 2 issue supports capital. Risk 6/10: credit cycle and transition.

What could invalidate the thesis

NIM 6.69% vs 7.24%; adjusted credit cost 1.12%; CEO transition.

Next-quarter investment decision tests

ROA, adjusted credit cost, funding and successor approval.

Key takeaways

  • For an investment decision, assess the normalized return on equity against the cost of equity and current, separately verified book-value multiple.
  • Positive operating evidence is not a buy signal by itself.
  • Do not use the editorial score as a target price or return forecast.

Evidence scope: TRANSCRIPT_ONLY; confidence MEDIUM. Independent statutory, peer-valuation and forward-model reconciliation remains incomplete. The sector comparison is shared; the opening analysis is issuer-specific.\n\n---\n\n

Bank-specific conditional scenarios — Q2 FY27 analyst assessment

Key takeaways

  • Evidence anchors. Q2 PAT was ₹218 crore against ₹24 crore a year earlier and ROA was 1.31%, but reported NIM fell from 7.24% to 6.69%, a 55-basis-point sequential decline.
  • Advances grew about 30% while deposits rose 19%; the management FY27 ROA expectation was raised to 1.35% from 1.2%.
  • Credit-cost measures require separation of ARC effects.

The CEO succession process is a separate execution dependency.

Bull case — conditional: Lower fresh microfinance and vehicle slippages allow genuine recurring credit costs to decline, stronger deposits improve funding stability, and operating earnings cover customer-acquisition costs. The 1.35% ROA aspiration becomes credible only when achieved through sustainable spreads and cash collections rather than temporary sale/recovery credits.

Base case — conditional: A rapid loan-book expansion preserves fee/interest growth but liability repricing and a larger secured mix constrain NIM. Underlying profitability improves gradually and the succession transition proceeds without changing underwriting discipline. No assumed 1.35% ROA is booked as a fact.

Bear case — conditional: Loan growth outpaces deposits, credit costs rise when ARC-related benefits fade, or successor uncertainty disrupts deposit mobilization. A 6.69% NIM trending lower while operating costs rise could offset the strong year-on-year PAT rebound.

Next quarter: Ask for ex-ARC credit-cost reconciliation, PAR/early delinquency by vintage, deposit growth on identical bases, NIM, CASA and leadership/regulatory milestones. A current stock target is not implied by these scenarios.

Additional company-specific Q2 FY27 financial evidence

Key takeaways

  • These observations and monitoring tests are reused from this company's existing published visual research deck.
  • The figures preserve their original evidence labels; assumptions are not company guidance or newly verified facts.

Investment decision · PAT YoY

Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO succession is another execution hinge. Compare with Ujjivan and Jana on recurring credit cost and secured portfolio economics. The raised FY27 ROA ambition is a measurable delivery test.

What the report says: Recovery is material; NIM fell QoQ.

Next observation: ROA, adjusted credit cost, funding and successor approval.

PAT YoY (₹ cr)

ObservationExisting figure
Prior year24
Current218

*Original chart source/basis:* Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.

Growth

Funding trails credit.

What the report says: Funding trails credit.

Next observation: Review the dated investment thesis and monitoring tests in the full report.

Growth (%)

ObservationExisting figure
Advances30
Deposits19

*Original chart source/basis:* Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.

FY27 ROA guidance

Guidance not actual; Q2 ROA 1.31%.

What the report says: Guidance not actual; Q2 ROA 1.31%.

Next observation: Review the dated investment thesis and monitoring tests in the full report.

FY27 ROA guidance (%)

ObservationExisting figure
Previous1.2
Revised1.35

*Original chart source/basis:* Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.

Quarterly earnings trajectory

Standalone profit: ₹24.0 cr to ₹218.0 cr over five quarters

What the report says: Five same-basis quarterly profit observations, Sep 2025–Sep 2026. This historical series may differ from bank-only figures in the decision summary; no mixing of reporting bases.

Next observation: Separate recurring earnings from one-offs; check the original filings before valuation.

Quarterly net profit · Standalone (₹ cr)

ObservationExisting figure
Sep 2524.0
Dec 2590.0
Mar 26213.0
Jun 26184.0
Sep 26218.0

*Original chart source/basis:* SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified):

Year-on-year earnings change

Separate profit recovery from a low or negative comparison base

What the report says: Each bar is current-quarter net profit minus same-quarter prior-year net profit in ₹ crore, not a percentage. Negative values indicate deterioration. Same reporting basis throughout.

Next observation: Review the source report for provisions, treasury and exceptional items before extrapolating.

YoY absolute profit change · Standalone (₹ cr)

ObservationExisting figure
Sep 2511.0
Dec 2524.0
Mar 26171.0
Jun 26408.0
Sep 26194.0

*Original chart source/basis:* Calculated from SAGE PRO dated canonical research snapshot, current/prior observations: ;

Trailing earnings power

Four-quarter earnings reduce reliance on a single result

What the report says: Trailing four-quarter sum of same-basis net profit; no annualization, adjustment or forecast. Only contiguous four-quarter windows are plotted.

Next observation: Check whether the trailing trend is supported by recurring NII, fee income, funding and credit costs.

Trailing four-quarter net profit · Standalone (₹ cr)

ObservationExisting figure
Sep 25-92.0
Dec 25-68.0
Mar 26103.0
Jun 26511.0
Sep 26705.0

*Original chart source/basis:* Calculated from SAGE PRO dated canonical research snapshot:

Return hurdle

Reported ROA is close to the revised FY27 ambition

What the report says: Quarterly ROA 1.31%, revised FY27 guidance 1.35%. Guidance is conditional and uses the issuer's annualised reporting basis.

Next observation: Track credit costs, deposit funding and NIM.

ROA: reported versus management guidance (%)

ObservationExisting figure
Q2 actual1.31
FY27 guidance1.35

*Original chart source/basis:* Existing SAGE PRO Q2 FY27 issuer-specific available-source assessment; original issuer/exchange evidence retained in the report source ledger. Any derived value is explicitly identified.

Credit growth · peer context

EQUITASBNK: compare credit growth with relevant lenders

What the report says: Reported loan or advances growth, with issuer-specific gross/net and perimeter differences. FCNR/IBU and IBPC effects are included where the issuer's headline does; do not treat this as normalized organic growth.

Next observation: Reconcile comparable organic growth and funding before peer valuation.

Q2 FY27 reported loan/advance growth YoY · Selected small finance banks (%)

ObservationExisting figure
AUBANK25
EQUITASBNK (company)30
SURYODAY34.6
UJJIVANSFB32.1
UTKARSHBNK7.5

*Original chart source/basis:* SAGE PRO banking sector research and the listed issuers' Q2 FY27 published evidence registers. Reported observations; not independent standardized peer reconciliation.

Deposit growth · peer context

EQUITASBNK: compare deposit growth with relevant lenders

What the report says: Reported year-on-year deposit growth as disclosed; definitions and special foreign-currency flows may differ. Not a common-perimeter deposit-beta comparison.

Next observation: Examine granular deposits and the cost of incremental funding.

Q2 FY27 reported deposit growth YoY · Selected small finance banks (%)

ObservationExisting figure
AUBANK29
EQUITASBNK (company)19
SURYODAY35
UJJIVANSFB29.2
UTKARSHBNK7

*Original chart source/basis:* SAGE PRO banking sector research and the listed issuers' Q2 FY27 published evidence registers. Reported observations; not independent standardized peer reconciliation.

Earnings relative to peers

Compare the earnings scale and momentum on a like-for-like reporting basis

What the report says: Selected banks are compared using the same period and reporting basis (standalone or consolidated). Absolute changes avoid misleading percentage growth from losses or low bases. Profit size also reflects scale, not efficiency; these are not ROA comparisons.

Next observation: Use the peer evidence alongside asset quality, funding and return metrics; cross-check historical figures with issuer filings before investment.

Q2 FY27 net profit · Standalone · Selected bank peers (₹ cr)

ObservationExisting figure
AUBANK858.0
UJJIVANSFB365.0
EQUITASBNK (company)218.0
JSFB170.0
ESAFSFB160.0
SURYODAY77.0
UTKARSHBNK-70.0

*Original chart source/basis:* SAGE PRO dated canonical research financial snapshots; same reporting basis and quarter, secondary historical sources (not independently reverified). Calculated as labeled. AUBANK: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | EQUITASBNK: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | ESAFSFB: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | JSFB: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | SURYODAY: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | UJJIVANSFB: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | UTKARSHBNK: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified):

Existing issuer and exchange evidence links

Banking sector peer research

Key takeaways

Additional company evidence

CHART 5

YoY absolute profit change · Standalone

Sep 25₹11 cr
Dec 25₹24 cr
Mar 26₹171 cr
Jun 26₹408 cr
Sep 26₹194 cr

Calculated from SAGE PRO dated canonical research snapshot, current/prior observations: ;

CHART 6

Trailing four-quarter net profit · Standalone

Sep 25₹-92 cr
Dec 25₹-68 cr
Mar 26₹103 cr
Jun 26₹511 cr
Sep 26₹705 cr

Calculated from SAGE PRO dated canonical research snapshot:

CHART 7

ROA: reported versus management guidance

Q2 actual1.31%
FY27 guidance1.35%

Existing SAGE PRO Q2 FY27 issuer-specific available-source assessment; original issuer/exchange evidence retained in the report source ledger. Any derived value is explicitly identified.

CHART 8

Q2 FY27 reported loan/advance growth YoY · Selected small finance banks

AUBANK25%
EQUITASBNK (company)30%
SURYODAY34.6%
UJJIVANSFB32.1%
UTKARSHBNK7.5%

SAGE PRO banking sector research and the listed issuers' Q2 FY27 published evidence registers. Reported observations; not independent standardized peer reconciliation.

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Q2 FY27 original exchange financial result filing

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.